2002
DOI: 10.1074/jbc.m207987200
|View full text |Cite
|
Sign up to set email alerts
|

A Role for the Middle C Terminus of G-protein-activated Inward Rectifier Potassium Channels in Regulating Gating

Abstract: We have used sulfhydryl-modifying reagents to investigate the regulation of G-protein-activated inward rectifier potassium (GIRK) channels via their cytoplasmic domains. Modification of either the conserved N-terminal cysteines (GIRK1C53 and GIRK2C65) or the middle C-terminal cysteines (GIRK1C310 and GIRK2C321) independently inhibited GIRK1/GIRK2 heteromeric channels. With the exception of GIRK2C65, these cysteines were relatively inaccessible to large modifying reagents. The accessibility was further reduced … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 37 publications
1
16
0
Order By: Relevance
“…28 The alkylation by sulfhydryl-modifying reagents of Nterminal cysteine 65 (C65) and C-terminal cysteine 321 (C321) residues, both placed within the cytoplasmic domain of GIRK2 channel, determine the inhibition of GIRK mediated current in GIRK1/GIRK2 heteromeric channels. 29 In particular, the alkylation of C65 was shown to have a high impact in current modulation, and it was found to be considerably more accessible than C321 to sulfhydryl modifying reagents, as is also demonstrated by the X-ray crystallographic structure of murine GIRK2 channel (98.3% identity with human isoform) in the preopen conformation, once complexed with β−γ G-protein subunits, dioctanoyl-l-alpha-phosphatidyl-D-myo-inositol-4,5diphosphate (PIO), and Na + (PDB code 4KFM). For this reason, we assumed C65 as the specific cysteine residue to which DOPA-quinone would bind.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…28 The alkylation by sulfhydryl-modifying reagents of Nterminal cysteine 65 (C65) and C-terminal cysteine 321 (C321) residues, both placed within the cytoplasmic domain of GIRK2 channel, determine the inhibition of GIRK mediated current in GIRK1/GIRK2 heteromeric channels. 29 In particular, the alkylation of C65 was shown to have a high impact in current modulation, and it was found to be considerably more accessible than C321 to sulfhydryl modifying reagents, as is also demonstrated by the X-ray crystallographic structure of murine GIRK2 channel (98.3% identity with human isoform) in the preopen conformation, once complexed with β−γ G-protein subunits, dioctanoyl-l-alpha-phosphatidyl-D-myo-inositol-4,5diphosphate (PIO), and Na + (PDB code 4KFM). For this reason, we assumed C65 as the specific cysteine residue to which DOPA-quinone would bind.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…1b). Subsequent addition of a small molecular inhibitor of GIRK2 channels, MTS-HE (100 μM) 37 , abruptly slowed the rate of quenching, indicating closure of GIRK2 channels (‘GIRK2/PIP 2  + HE’, Fig. 1b).…”
Section: Resultsmentioning
confidence: 99%
“…To test this idea, we used a strategy of chemical modification in which a single cysteine is introduced at 5′K or 6′K and is then probed with a membrane permeant MTS compound. This technique has the advantage of enabling the study of a channel before and after modification and has been used previously to probe gating structures of inwardly rectifying potassium channels ( Guo et al, 2002 ; Lopes et al, 2002 ; Xiao et al, 2003 ; Bodhinathan and Slesinger, 2013 ). Here, we focused on the effect of MTS hydroxyethyl (HE), which would covalently attach a CH 2 -CH 2 -OH side chain to the sulfhydryl of the engineered cysteine, mimicking a serine/threonine type of amino acid substitution, i.e., a polar, uncharged residue.…”
Section: Resultsmentioning
confidence: 99%